Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heini Salo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|May 8, 2002
Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosisHeini Salo, Markku Pekurinen
Duodecim; Laaketieteellinen Aikakauskirja|December 15, 2017
National vaccination program - a success story of public health and economyHeini Salo, Terhi Kilpi
Duodecim; Laaketieteellinen Aikakauskirja|September 17, 2002
[Economic evaluation of an immunization program]Heini Salo, Harri Sintonen
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Evidence-based cesarean section]Heini Salo, Aydin Tekay, Kaarin Mäkikallio
Duodecim; Laaketieteellinen Aikakauskirja|November 21, 2007
[Not Available]Terho Heikkinen, Heini Salo, Terhi Kilpi
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 5, 2025
Herpes zoster incidence in adults aged ≥ 20 years in Finland, 2015 to 2023: a population-based register studyAapo Juutinen, Heini Salo, Toni Lehtonen, et al.
Infectious Diseases (London, England)|July 20, 2022
Health care costs related to hepatitis B in Finland are mostly due to chronic infections: a register-based studyTanja Nieminen, Heini Salo, Markku Nurhonen, et al.
Vaccine|September 13, 2017
Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcareTuija Leino, Ulrike Baum, Peter Scott, et al.
Vaccine|November 6, 2012
First year experience of rotavirus immunisation programme in FinlandTuija Leino, Jukka Ollgren, Heini Salo, et al.
Vaccine|April 30, 2022
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinationsHeini Salo, Toni Lehtonen, Kari Auranen, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|May 8, 2002
Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosisHeini Salo, Markku Pekurinen
Duodecim; Laaketieteellinen Aikakauskirja|December 15, 2017
National vaccination program - a success story of public health and economyHeini Salo, Terhi Kilpi
Duodecim; Laaketieteellinen Aikakauskirja|September 17, 2002
[Economic evaluation of an immunization program]Heini Salo, Harri Sintonen
Duodecim; Laaketieteellinen Aikakauskirja|August 7, 2015
[Evidence-based cesarean section]Heini Salo, Aydin Tekay, Kaarin Mäkikallio
Duodecim; Laaketieteellinen Aikakauskirja|November 21, 2007
[Not Available]Terho Heikkinen, Heini Salo, Terhi Kilpi
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 5, 2025
Herpes zoster incidence in adults aged ≥ 20 years in Finland, 2015 to 2023: a population-based register studyAapo Juutinen, Heini Salo, Toni Lehtonen, et al.
Infectious Diseases (London, England)|July 20, 2022
Health care costs related to hepatitis B in Finland are mostly due to chronic infections: a register-based studyTanja Nieminen, Heini Salo, Markku Nurhonen, et al.
Vaccine|September 13, 2017
Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcareTuija Leino, Ulrike Baum, Peter Scott, et al.
Vaccine|November 6, 2012
First year experience of rotavirus immunisation programme in FinlandTuija Leino, Jukka Ollgren, Heini Salo, et al.
Vaccine|April 30, 2022
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinationsHeini Salo, Toni Lehtonen, Kari Auranen, et al.
Pageof 4